Clinical Trials Directory

Trials / Completed

CompletedNCT04601350

Effect of Remimazolam Use During Perioperative Period on Brain Waves and Postoperative Cognitive Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Yangzhou University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Benzodiazepine sedative hypnotics are commonly used intravenous anesthetics in clinical practice. Remimazolam is a new benzodiazepine with the characteristics of rapid onset, short maintenance and recovery time, no accumulation, metabolism independent of liver and kidney function, and no serious side effects, which has a good prospect for clinical application. Now we will study the effects of remimazolam on EEG and postoperative cognitive function ,in order to further understand the clinical application of remimazolam.

Conditions

Interventions

TypeNameDescription
DRUGremimazolam group was induced with remimazolam 0.1 mg/kg followed by a maintenance dose of 0.1 mg·kg-1·h-1 for general anesthesiaremimazolam group was remimazolam 0.1 mg/kg followed by a maintenance dose of 0.1 mg·kg-1·h-1 for general anesthesia
DRUGcontrol group was induced with midazolam 0.05 mg/kg followed by normal saline maintenance of 0.1 ml·kg-1·h-1control group was induced with midazolam 0.05 mg/kg followed by normal saline maintenance of 0.1 ml·kg-1·h-1

Timeline

Start date
2020-11-01
Primary completion
2022-05-01
Completion
2022-06-01
First posted
2020-10-23
Last updated
2024-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04601350. Inclusion in this directory is not an endorsement.